Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in
- This topic has 0 replies, 1 voice, and was last updated 1 year, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements.
https://meetings.asco.org/abstracts-presentations/208022
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.